IPSC icon

Century Therapeutics

0.5633 USD
+0.0148
2.7%
At close Updated Nov 11, 4:00 PM EST
Pre-market
After hours
0.5633
0.0000
0%
1 day
2.7%
5 days
-2.9%
1 month
2.44%
3 months
15.05%
6 months
7.36%
Year to date
-45.84%
1 year
-61.68%
5 years
-97.53%
10 years
-97.53%
 

About: Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Employees: 165

0
Funds holding %
of 7,512 funds
Analysts bullish %
Positive news %
Price charts implemented using Lightweight Charts™